Rithm Capital Sets Q3 2022 Common And Preferred Dividends If $0.25 Per Share

Rithm Capital Corp. (NYSE:RITM, ", Rithm Capital", or the ", Company", )))) announced today that its Board of Directors (the "Board") has declared third quarter 2022 common and

Rithm Capital Corp. (NYSE:RITM, &quot, Rithm Capital&quot, or the &quot, Company&quot, ))))) announced today that its Board of Directors (the "Board") has declared third quarter 2022 common and preferred stock dividends.

Common Stock Dividend

The Board declared a quarterly dividend of $0.25 per share of common stock for the third quarter 2022. The third quarter common stock dividend is payable on October 28, 2022 to shareholders of record on October 4, 2022.

Preferred Stock Dividends

In accordance with the terms of Rithm Capital's 7.50% Series A Cumulative Redeemable Preferred Stock ("Series A"), the Board declared a Series A dividend for the third quarter 2022 of $0.4687500 per share.

In accordance with the terms of Rithm Capital's 7.125% Series B Cumulative Redeemable Preferred Stock ("Series B"), the Board declared a Series B dividend for the third quarter 2022 of $0.4453125 per share.

In accordance with the terms of Rithm Capital's 6.375% Series C Cumulative Redeemable Preferred Stock ("Series C"), the Board declared a Series C dividend for the third quarter 2022 of $0.3984375 per share.

In accordance with the terms of Rithm Capital's 7.00% Series D Fixed-Rate Reset Cumulative Redeemable Preferred Stock ("Series D"), the Board declared a Series D dividend for the third quarter 2022 of $0.4375000 per share.

Dividends for the Series A, Series B, Series C and Series D are payable on November 15, 2022 to preferred shareholders of record on October 17, 2022.

ABOUT RITHM CAPITAL

Total
0
Shares
Related Posts
Read More

Reported Late Tuesday, Eisai And Biogen Present Full Results Of Lecanemab Phase 3 Confirmatory Clarity AD Study For Early Alzheimer’s Disease At Clinical Trials On Alzheimer’s Disease Conference: Primary And Key Secondary Endpoints Were Changed From Ba…

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (NASDAQ:BIIB, Corporate headquarters: , Cambridge, Massachusetts, CEO: , Christopher A.

BIIB